Growth Metrics

Labcorp Holdings (LH) Current Deferred Revenue (2016 - 2026)

Labcorp Holdings' Current Deferred Revenue history spans 12 years, with the latest figure at $405.2 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 4.35% to $405.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $405.2 million, a 4.35% increase, with the full-year FY2025 number at $439.1 million, up 11.96% from a year prior.
  • Current Deferred Revenue hit $405.2 million in Q1 2026 for Labcorp Holdings, down from $439.1 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for LH hit a ceiling of $586.7 million in Q1 2023 and a floor of $310.6 million in Q4 2022.
  • Historically, Current Deferred Revenue has averaged $426.1 million across 5 years, with a median of $398.0 million in 2025.
  • Biggest five-year swings in Current Deferred Revenue: crashed 44.39% in 2022 and later surged 35.77% in 2023.
  • Tracing LH's Current Deferred Revenue over 5 years: stood at $310.6 million in 2022, then surged by 35.77% to $421.7 million in 2023, then fell by 7.0% to $392.2 million in 2024, then rose by 11.96% to $439.1 million in 2025, then fell by 7.72% to $405.2 million in 2026.
  • Business Quant data shows Current Deferred Revenue for LH at $405.2 million in Q1 2026, $439.1 million in Q4 2025, and $391.6 million in Q3 2025.